Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Ensysce Biosciences, Inc. - Common Stock (NQ: ENSC )

5.800 -0.250 (-4.13%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Why Skechers Shares Are Trading Lower; Here Are 25 Stocks Moving Premarket
Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) rose 53.5% to $0.32 in pre-market trading after gaining 13% on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers DBV Technologies (NASDAQ:DBVT) stock increased by 18.7% to $1.9 during Tuesday's after-market session. The company's market cap stands at $356.7 million. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Why Olaplex Holdings Shares Are Trading Lower By 42%; Here Are 27 Stocks Moving Premarket
Gainers SenesTech, Inc. (NASDAQ: SNES) shares rose 65.8% to $0.3847 in pre-market trading after declining over 3% on Tuesday. 
Via Benzinga
Ensysce Biosciences Announces Initiation of Second Human Abuse Potential Study, Being Conducted by DVCR
Via ACCESSWIRE
Ensysce Biosciences Reminds Shareholders to Vote at Upcoming Special Meeting
Via ACCESSWIRE
Why NLS Pharmaceutics Shares Dipped Over 23%; Here Are 67 Biggest Movers From Yesterday
Gainers 
Via Benzinga
This Innovative Biotech Firm Is Changing The Way We See Medication
Sign up for this week’s All Access giveaway here! Dr. Lynn Kirkpatrick, CEO of Ensysce Biosciences (NASDAQ: ENSC), was a guest on Benzinga’s All Access on Sep 23, 2022. 
Via Benzinga
Ensysce Biosciences, Quotient Partner To Work On Novel Opioid To Prevent Abuse and Overdose
Via Benzinga
Ensysce Biosciences Announces Completion of Clinical Portion of Human Abuse Potential Trial PF614-103
Via ACCESSWIRE
Ensysce Biosciences Releases Updated Investor Presentation Ahead of Corporate Update Call
Via ACCESSWIRE
Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket
Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Pulmatrix (NASDAQ:PULM) shares rose 11.9% to $4.3 during Wednesday's after-market session. The company's market cap stands at $14.5 million. 
Via Benzinga
Ensysce Biosciences to Present at Benzinga All Access Event on Friday, September 23, 2022
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
  
Via Benzinga
Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket
Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers Enochian BioSciences (NASDAQ:ENOB) shares moved upwards by 27.8% to $2.3 during Wednesday's after-market session. The market value of their outstanding shares is at $121.7 million. 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with an overview of the biggest pre-market stock movers this morning and the news moving those shares! 
Via InvestorPlace
Why Kaspien Holdings Is Trading Lower By 13%; Here Are 21 Stocks Moving Premarket
Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 54.3% to $28.56 in pre-market trading following effect of 1:50 reverse stock split. 
Via Benzinga
Why Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday
Gainers Akero Therapeutics, Inc. (NASDAQ: AKRO) shares jumped 136.8% to settle at $29.05 on Tuesday after the company's Phase 2b HARMONY study met its primary endpoint for both the 50mg and 28mg EFX... 
Via Benzinga
Why ShiftPixy Surged Around 177%; Here Are 71 Biggest Movers From Yesterday
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 176.5% to close at $31.00 on Thursday after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to... 
Via Benzinga
Ensysce Biosciences Announces Results of Special Meeting of Stockholders
Via ACCESSWIRE
Why Bilibili Is Trading Lower By Over Around 14%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares jumped 73.8% to $19.48 after the company announced plans to spin-off ShiftPixy Labs and dividend its digital securities to shareholders. 
Via Benzinga
Ensysce Biosciences Debuts Redesigned Company Website to Highlight its TAAP(TM) and MPAR(TM) Technologies and Growing Product Pipeline
Via ACCESSWIRE
Ensysce Biosciences, Inc. Announces Participation in Upcoming Conferences
Via ACCESSWIRE
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
  
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving! 
Via InvestorPlace
Why FlexShopper Surged Over 47%; Here Are 104 Biggest Movers From Yesterday
Gainers Digital Media Solutions, Inc. (NYSE: DMS) jumped 78.8% to close at $2.11. Digital Media Solutions recently reported worse-than-expected Q2 EPS and sales results. 
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.